¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦13ȸ ¿µ³²½ÉÇ÷°üÁßÀçÇÐȸ ½ÉÆ÷Áö¾ö : 2018-11-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦13ȸ ¿µ³²½ÉÇ÷°üÁßÀçÇÐȸ ½ÉÆ÷Áö¾ö : 2018-11-24
±³À°ÀÏÀÚ : 2018-11-24
±³À°Àå¼Ò : °æÁÖ È­¹éÄÁº¥¼Ç¼¾ÅÍ 1Ãþ 101  
±³À°ÁÖÁ¦ : Á¦13ȸ ¿µ³²½ÉÇ÷°üÁßÀçÇÐȸ ½ÉÆ÷Áö¾ö      
ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
´ã´çÀÚ : Á¤ÀºÇý
¿¬¶ôó : 02-582-8212  
À̸ÞÀÏ : grace@kscvi.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : °æ»óºÏµµ
±³À°½Ã°£ : 7 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-24 101 09:00~09:15 In PCI, Are Female Patients Just Like Men?  ¼Û¿©Á¤(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 11-24 101 09:15~09:30 High-output Mechanical Circulatory Support Devices for Cardiogenic Shock after MI: ECMO vsersus Impella CP/5.0  Àå¿ìÁø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-24 101 09:30~09:45 Revascularization Decisions in Cardiogenic Shock  Á¶À±°æ(°è¸íÀÇ´ë) 
Åä·Ð 11-24 101 09:45~10:00 Discussion  () 
±³À°½Ã°£ 11-24 101 10:00~10:15 Cardiologist¡¯s Opinion: Problem Is Pre-hospital Delays in STEMI  ¹èÁØÈ£(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24 101 10:15~10:30 Epidemiologist's Opinion: Problem Is Analysis of Mortality through Statistics  ±èµ¿Çö(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 11-24 101 10:30~10:45 Rehabilitation Doctor's Opinion: Problem Is Rehabilitation  À̺´ÁÖ(ºÎ»êÀÇ´ë) 
Åä·Ð 11-24 101 10:45~11:00 Discussion  () 
È޽Ġ11-24  11:00~11:15 Coffee Break  () 
±³À°½Ã°£ 11-24 101 11:15~11:30 CTO-PCI - A Symptomatic or a Life Saving Therapy?  ½Åµ¿È£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-24 101 11:30~11:45 Innovative Procedure for the Percutaneous Recanalization of CTO  Shigeru Nakamura(Kyoto Katsura Hospital. Japan) 
±³À°½Ã°£ 11-24 101 11:45~12:00 Antegrade Wire Escalation Technique; Status 2018  ÀÌÀåÈÆ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 11-24 101 12:00~12:15 CTO - My top 10 Recommendations for a Successful Procedure  Masaharu Okada(Shiga General Hospital. Japan) 
Åä·Ð 11-24 101 12:15~12:30 Discussion  () 
±³À°½Ã°£ 11-24 101 12:30~12:45 Re-defining The Role of Ticagrelor in ACS; From PLATO To Real World Evidence  ¹éÁÖ¿­(ûÁÖ¼º¸ðº´¿ø) 
±³À°½Ã°£ 11-24 101 12:45~13:00 How to Optimize DAPT in High Risk Post MI Patients; Insights From PEGASUS TIMI-54  ÀÌöȯ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-24 101 13:00~13:15 New Strategy of Anti-Platelet Treatment with Ticagrelor; Insights from Global Leaders  ¹èÀåȯ(ÃæºÏÀÇ´ë) 
Åä·Ð 11-24 101 13:15~13:30 Discussion  () 
È޽Ġ11-24  13:30~13:45 Coffee Break  () 
±³À°½Ã°£ 11-24 101 13:45~14:00 PCI in Stable Angina: COURAGE and ORBITA Trial  ÀÌ»ó¿±(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 11-24 101 14:00~14:15 Does ORBITA Change Our Approach? NO  ±è½Âȯ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 11-24 101 14:15~14:30 Does ORBITA Change Our Approach? YES  ±è¿õ(¿µ³²ÀÇ´ë) 
Åä·Ð 11-24 101 14:30~14:45 Discussion  () 
±³À°½Ã°£ 11-24 101 14:45~15:00 Current Status of Lesion Preparation in Coronary Intervention  È«½ÂÇ¥(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-24 101 15:00~15:15 Hemodynamic Device Support for PCI- Which and When?  ¹Ú°æ¹Î(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-24 101 15:15~15:30 The STEMI Patient in Cardiogenic Shock: How to Proceed  À±ÇõÁØ(°è¸íÀÇ´ë) 
Åä·Ð 11-24 101 15:30~15:45 Discussion  () 
È޽Ġ11-24  15:45~16:00 Coffee Break  () 
±³À°½Ã°£ 11-24 101 16:00~16:15 Predictable or Unpredictable Complications during Coronary Intervention of Cardiac Arrest Patient  ÀÌöÇö(°è¸íÀÇ´ë) 
±³À°½Ã°£ 11-24 101 16:15~16:30 à´Ôéò¢è«  Ãµ¹Î±¸(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 11-24 101 16:30~16:45 A Terrible Experience in Severe and Complex Calcified Coronary Artery Lesions  Á¤¼ºÀ±(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 11-24 101 16:45~17:00 Aortic Dissection during PCI  ¹ÚÇö¿õ(°æ»óÀÇ´ë) 
±³À°½Ã°£ 11-24 101 17:00~17:15 Obstacle to Overcome  ±èÈ«·Ã(°æºÏÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦13ȸ ¿µ³²½ÉÇ÷°üÁßÀçÇÐȸ ½ÉÆ÷Áö¾ö : 2018-11-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ºÎ»ê´ëÇб³º´¿ø 2018³â ôÃ߽Űæ¿Ü°ú¡¤Á¤Çü¿Ü°ú ºÎ¿ï°æÁöȸ ¿¬ÇÕ ½ÉÆ÷Áö¿ò : 2018-11-24
´ÙÀ½±Û ÀÎÁ¦´ëÇб³¼­¿ï¹éº´¿ø 2018 Á¦2ȸ Paik Master Class ¿¬¼ö°­Á : 2018-11-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 3 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 3 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 108 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 11 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 35 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 10 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 6 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 4 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 3 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 1 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 7 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 1 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 9 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 2 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 8 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷